Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapyMichiko Tsuneizumi, Yusuke Nakamura, Akira Hirano et al.|Cancer Letters|2002Cited by 64
Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivoKoji Tsumagari, Emad Kandil|Endocrine Related Cancer|2017Cited by 28